The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 75
Updated:3/15/2019
Start Date:August 2006
End Date:December 2008

Use our guide to learn which trials are right for you!

The purpose of this study is to investigate whether there is a difference in endothelial
function, heart rate variability and carotid intimal media thickness in patients with
coronary artery disease who are receiving fish oil therapy.

One hundred patients with established coronary artery disease by coronary angiography will
undergo randomization for enrollment in the study. Baseline evaluation will include
assessment of brachial artery endothelial function, heart rate variability and carotid
intimal media thickness. Evaluation of the endothelial function of the brachial artery will
be elucidated by inflation of a blood pressure cuff around the arm for five minutes and
measuring blood vessel dynamics after release of the cuff. Heart rate variability will be
evaluated by 24 hour holter monitoring and analysis by standard protocol. Carotid intimal
media thickness will be evaluated by ultrasound measurements guided by predetermined
protocol. Patients will then be randomized to a highly purified fish oil, Omacor, 1 gram
twice a day or placebo. Brachial artery ultrasound and holter monitoring will be repeated at
2 months. Carotid ultrasound will be repeated at the end of the study at 12 months.


Inclusion Criteria:

1. Established coronary artery disease as determined by coronary angiography within the
last 5 years demonstrating at least 50% stenosis in one of the major coronary vessels

2. Age >18 and <75.

Exclusion Criteria:

1. Baseline fish oil intake ≥1g/day or fish intake >100g/day

2. Need for urgent or emergent CABG

3. Contraindication for plavix, aspirin or statin

4. Gastrointestinal malabsorption syndrome

5. Pregnancy

6. Oral contraceptive use

7. Ejection fraction <40%

8. Underlying atrial or ventricular arrhythmia

9. History of rheumatoid arthritis
We found this trial at
1
site
Sylmar, California 91342
?
mi
from
Sylmar, CA
Click here to add this to my saved trials